Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Bunnage

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Nature Chemical Biology|May 19, 2011
Getting pharmaceutical R&D back on targetMark E Bunnage
Current Opinion in Drug Discovery & Development|July 5, 2008
TAFIa inhibitors in the treatment of thrombosisMark E Bunnage, Dafydd R Owen
Nature Reviews. Drug Discovery|January 21, 2017
Applications of chemogenomic library screening in drug discoveryLyn H Jones, Mark E Bunnage
Nature Chemical Biology|March 20, 2013
Target validation using chemical probesMark E Bunnage, Eugene L Piatnitski Chekler, Lyn H Jones
Nature Chemical Biology|May 17, 2015
Know your target, know your moleculeMark E Bunnage, Adam M Gilbert, Lyn H Jones, et al.
Organic Letters|January 31, 2003
Asymmetric synthesis of the putative structure of (-)-oryzoxymycinMark E Bunnage, Thota Ganesh, Ishmael B Masesane, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
Highly potent and selective chiral inhibitors of PDE5: an illustration of Pfeiffer's ruleMark E Bunnage, John P Mathias, Anthony Wood, et al.
Organic & Biomolecular Chemistry|September 30, 2004
Asymmetric synthesis of the cis- and trans-stereoisomers of 4-aminopyrrolidine-3-carboxylic acid and 4-aminotetrahydrofuran-3-carboxylic acidMark E Bunnage, Stephen G Davies, Paul M Roberts, et al.
Organic & Biomolecular Chemistry|December 3, 2003
Asymmetric synthesis of (1R,2S,3R)-3-methylcispentacin and (1S,2S,3R)-3-methyltranspentacin by kinetic resolution of tert-butyl (+/-)-3-methylcyclopentene-1-carboxylateMark E Bunnage, Ann M Chippindale, Stephen G Davies, et al.
Organic & Biomolecular Chemistry|November 10, 2004
Kinetic resolution of tert-butyl (RS)-3-alkylcyclopentene-1-carboxylates for the synthesis of homochiral 3-alkyl-cispentacin and 3-alkyl-transpentacin derivativesMark E Bunnage, Stephen G Davies, Richard M Parkin, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Nature Chemical Biology|May 19, 2011
Getting pharmaceutical R&D back on targetMark E Bunnage
Current Opinion in Drug Discovery & Development|July 5, 2008
TAFIa inhibitors in the treatment of thrombosisMark E Bunnage, Dafydd R Owen
Nature Reviews. Drug Discovery|January 21, 2017
Applications of chemogenomic library screening in drug discoveryLyn H Jones, Mark E Bunnage
Nature Chemical Biology|March 20, 2013
Target validation using chemical probesMark E Bunnage, Eugene L Piatnitski Chekler, Lyn H Jones
Nature Chemical Biology|May 17, 2015
Know your target, know your moleculeMark E Bunnage, Adam M Gilbert, Lyn H Jones, et al.
Organic Letters|January 31, 2003
Asymmetric synthesis of the putative structure of (-)-oryzoxymycinMark E Bunnage, Thota Ganesh, Ishmael B Masesane, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
Highly potent and selective chiral inhibitors of PDE5: an illustration of Pfeiffer's ruleMark E Bunnage, John P Mathias, Anthony Wood, et al.
Organic & Biomolecular Chemistry|September 30, 2004
Asymmetric synthesis of the cis- and trans-stereoisomers of 4-aminopyrrolidine-3-carboxylic acid and 4-aminotetrahydrofuran-3-carboxylic acidMark E Bunnage, Stephen G Davies, Paul M Roberts, et al.
Organic & Biomolecular Chemistry|December 3, 2003
Asymmetric synthesis of (1R,2S,3R)-3-methylcispentacin and (1S,2S,3R)-3-methyltranspentacin by kinetic resolution of tert-butyl (+/-)-3-methylcyclopentene-1-carboxylateMark E Bunnage, Ann M Chippindale, Stephen G Davies, et al.
Organic & Biomolecular Chemistry|November 10, 2004
Kinetic resolution of tert-butyl (RS)-3-alkylcyclopentene-1-carboxylates for the synthesis of homochiral 3-alkyl-cispentacin and 3-alkyl-transpentacin derivativesMark E Bunnage, Stephen G Davies, Richard M Parkin, et al.
Pageof 4